Success Metrics

Clinical Success Rate
87.5%

Based on 14 completed trials

Completion Rate
88%(14/16)
Active Trials
1(5%)
Results Posted
14%(2 trials)
Terminated
2(10%)

Phase Distribution

Ph not_applicable
18
86%
Ph phase_2
2
10%
Ph phase_3
1
5%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution21 total trials
Phase 2Efficacy & side effects
2(9.5%)
Phase 3Large-scale testing
1(4.8%)
N/ANon-phased studies
18(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

14 of 16 finished

Non-Completion Rate

12.5%

2 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(14)
Terminated(2)
Other(3)

Detailed Status

Completed14
unknown3
Terminated2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (9.5%)
Phase 31 (4.8%)
N/A18 (85.7%)

Trials by Status

completed1467%
enrolling_by_invitation15%
recruiting15%
terminated210%
unknown314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05636293Phase 2

Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission

Completed
NCT04530123Phase 2

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

Completed
NCT06900946Not Applicable

Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With Non-celiac Gluten Sensitivity

Enrolling By Invitation
NCT05894746Not Applicable

Gfree - For Improved Blood Sugar and Reduced Inflammation.

Recruiting
NCT03409796Not Applicable

Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge

Completed
NCT00931892Not Applicable

Serum Markers in Gluten Challenge

Completed
NCT03653689Not Applicable

Identification of IBS Metabotypes Based on Physiological Responses to Food

Completed
NCT03288831Not Applicable

Changes in Intestinal Permeability 4 Hours After Gluten Challenge

Completed
NCT03798262Not Applicable

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects

Completed
NCT03798249Not Applicable

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity

Unknown
NCT02895438Not Applicable

Non Coeliac Gluten Sensitivity in Children

Completed
NCT03101410Not Applicable

Gluten Sensibility in Elite Athletes

Completed
NCT01506349Not Applicable

Assessing Neurocognitive Effects of Gluten Exposure

Terminated
NCT03129906Not Applicable

Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients

Completed
NCT00819819Not Applicable

Infant Nutrition and Risk of Celiac Disease

Terminated
NCT01485341Phase 3

Gluten Sensitivity in Non-Celiac Patients

Completed
NCT01864993Not Applicable

Symptomatic Response to Gluten Challenge in Patients With Suspected Non Celiac Gluten Sensitivity

Completed
NCT02431585Not Applicable

Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics.

Unknown
NCT01827566Not Applicable

Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet

Unknown
NCT00863564Not Applicable

Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

Completed

Drug Details

Intervention Type
OTHER
Total Trials
21